2016
DOI: 10.1016/j.etap.2015.12.016
|View full text |Cite
|
Sign up to set email alerts
|

Di(2-ethylhexyl) phthalate exacerbates non-alcoholic fatty liver in rats and its potential mechanisms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
60
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(64 citation statements)
references
References 38 publications
3
60
0
1
Order By: Relevance
“…There is evidence that EDCs with similar modes of action (MoAs) can act together in an additive manner to produce more pronounced effects [15]. Additionally, there are studies on different experimental models that indicate the possibility of interaction between these chemicals, i.e., suggesting even synergism in their endocrine actions [7,[16][17][18][19]. Therefore, the utilization of real-life risk simulation (RLRS) concept in determining the combined effects of such chemicals is essential [19].…”
Section: Introductionmentioning
confidence: 99%
“…There is evidence that EDCs with similar modes of action (MoAs) can act together in an additive manner to produce more pronounced effects [15]. Additionally, there are studies on different experimental models that indicate the possibility of interaction between these chemicals, i.e., suggesting even synergism in their endocrine actions [7,[16][17][18][19]. Therefore, the utilization of real-life risk simulation (RLRS) concept in determining the combined effects of such chemicals is essential [19].…”
Section: Introductionmentioning
confidence: 99%
“…There are also reports about the influence of phthalates on the function of the human thyroid gland and immune system (Sathyanarayana, 2008). One of the types of phthalates (di(2-ethylhexyl) phthalate, or DEHP) causes increase in the weight of the liver, morphological and biochemical changes in it; it changes the activity of the main enzymes which metabolize medical substances and ethanol, mostly by inhibiting them (Seth, 1982;Chen et al, 2016;Liu et al, 2016). Increase of DEHP dose over 30 days caused changes in urine, which indicate the impact on energy metabolism, function of the liver and kidneys, metabolism of fatty acids and caused harm to DNA in rats (Dong et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…In chronic studies of high doses of DINP in rodents, de-crease in body weight, increase in mass of the liver and changes in histopathology of hepatocytes (hypertrophy) were observed. Prolonged impact of high doses of this substance even caused increase in frequency of tumours of the liver (adenoma and carcinoma) (Chen et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…In vitro на культурі клітин 3T3-L1 встановлено, що DEHP порушує інсулінову толерантність, але не впливає на метаболізм глюкози (Klöting N. et al, 2015). В інших дослідженнях на щурах показано, що DEHP може індукувати жирову трансформацію печінки протягом 8 тиж за рахунок активації ліпопероксидації та вивільнення прозапальних факторів у гепатоцитах, що порушує синтезуючу функцію печінки (Chen H. et al, 2016).…”
Section: фталати як фактори нерепродуктивних порушеньunclassified